Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study (Q33606102)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study |
scientific article |
Statements
1 reference
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study (English)
1 reference
Shailender Bhatia
Brendan Curti
Marc S Ernstoff
Michael Gordon
Elisabeth I Heath
Wilson H Miller
Thomas W Flaig
Peter VanVeldhuizen
Jeremy A Freeman
Rachel Bittner
Naomi Hunder
Sonia Souza
27 January 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference